Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An announcement from Extendicare ( (TSE:EXE) ) is now available.
Extendicare Inc. reported a 15.4% increase in adjusted EBITDA for Q2 2025, driven by growth in its home health care segment and improvements in long-term care, including the acquisition of nine Class C LTC homes. The company completed several strategic transactions, including the sale of three LTC projects and the acquisition of Closing the Gap, which is expected to enhance its service offerings and operational scale. These moves, along with increased credit facilities, position Extendicare for future growth and improved market positioning.
The most recent analyst rating on (TSE:EXE) stock is a Hold with a C$11.00 price target. To see the full list of analyst forecasts on Extendicare stock, see the TSE:EXE Stock Forecast page.
Spark’s Take on TSE:EXE Stock
According to Spark, TipRanks’ AI Analyst, TSE:EXE is a Neutral.
Extendicare’s strong earnings growth and strategic initiatives are significant positives, supported by its attractive dividend yield. However, technical analysis indicates bearish momentum, and financial leverage presents risks. The stock is currently rated as a Hold.
To see Spark’s full report on TSE:EXE stock, click here.
More about Extendicare
Extendicare Inc. operates in the healthcare industry, primarily focusing on providing long-term care and home health care services. The company is involved in managing and developing long-term care homes and offers a range of health services through its home health care segment.
Average Trading Volume: 181,495
Technical Sentiment Signal: Buy
Current Market Cap: C$1.06B
See more insights into EXE stock on TipRanks’ Stock Analysis page.